While it's long been known that bhepatitis B virus (HBV) infection is linked to a higher risk of liver cancer-specifically hepatocellular carcinoma
Vous n'êtes pas connecté
The gene signature for renal cancer can help clinicians identify recurrence risk earlier and potentially guide patient treatment strategies.
While it's long been known that bhepatitis B virus (HBV) infection is linked to a higher risk of liver cancer-specifically hepatocellular carcinoma
In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which...
bFanconi anemia is a serious and potentially fatal inherited disorder. /b Marked by bone marrow failure and an increased risk of...
The ESR1 mutated metastatic breast cancer diagnostics market is valued at USD 64.61 million in 2025 and is slated to reach USD 92.92 million by 2035,...
The ESR1 mutated metastatic breast cancer diagnostics market is valued at USD 64.61 million in 2025 and is slated to reach USD 92.92 million by 2035,...
A new study finds that hepatitis B heightens liver cancer risk by worsening inflammation and carcinogen impact, suggesting prevention through...
Acquired immune deficiency syndrome, or AIDS, caused by the human immunodeficiency virus (HIV), weakens the body's immune system and can be...
Vital chemotherapy drugs used around the world have failed quality tests, leaving cancer patients in more than 100 countries at risk of ineffective...
Vital chemotherapy drugs used around the world have failed quality tests, leaving cancer patients in more than 100 countries at risk of ineffective...
A new urine-based tumor DNA (utDNA) test shows promise in predicting treatment response and recurrence risk, helping personalize bladder cancer...